HCAR2 and colorectal cancer: 3OHB was shown to exhibit anti-colorectal cancer activity through G protein-coupled 109A (GPR109A, also known as hydroxyl-carboxylic acid receptor 2; HCAR2) binding and activation [38], a tumor suppressor that inhibits lipolysis in the adipocytes [28].